About Ofatumumab
            
            Class: | Monoclonal antibody (CD20 inhibitor)  
Use: | Treatment of relapsing forms of multiple sclerosis (MS) in adults  
Adult dose: | Initial dose: 20 mg subcutaneously at weeks 0, 1, and 2, followed by 20 mg once monthly  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Injection site reactions, headache, upper respiratory infections, fatigue, and increased risk of infections  
Contraindications: | Active infections, hypersensitivity to ofatumuma
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (CD20 inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of relapsing forms of multiple sclerosis (MS) in adults
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novartis Pharmaceuticals Corporation, U.S.A
                    
                    
                    Package Size
                    0.4ml Pre-filled Pen
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 7431.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 20 mg subcutaneously at weeks 0, 1, and 2, followed by 20 mg once monthly
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, headache, upper respiratory infections, fatigue, and increased risk of infections
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active infections, hypersensitivity to ofatumumab or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of serious infections, including progressive multifocal leukoencephalopathy (PML); monitor for signs of infection; pre-screen for hepatitis B virus (HBV) infection.
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal antibody (CD20 inhibitor) medicines available in UAE pharmacies
            
            
            
                Rituximab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.